BioNTech vaccination suspended
The Government today announced that it immediately suspended COVID-19 vaccinations concerning BioNTech after deviations in the vial seal were found in one batch of the vaccine.
It explained that it received written notification this morning from Fosun Industrial Co about the deviations that involve batch 210102.
The Government noted that while BioNTech and Fosun Pharma have no reason to believe there is a risk to product safety, for the sake of prudence, vaccination of the batch concerned should be suspended pending an investigation.
It added that batch 210104 of the BioNTech vaccine should also be put on hold and not be administered as a precautionary measure to ensure vaccine safety.
The Government stated that people who have made appointments to receive BioNTech vaccination from today onwards need not go to the community vaccination centres for vaccination.
The Department of Health will hold an urgent meeting with Fosun Industrial Co to obtain further details of the incident and discuss follow-up measures.